These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22191240)

  • 1. [Effect of monochromatic red lighting potentiating antitumor action of cyclophosphamide injected with autoblood].
    Sheĭko EA; Shikhliarova AI
    Vopr Onkol; 2011; 57(4):493-6. PubMed ID: 22191240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental use of low-energy infrared laser radiation to stimulate antitumor effect of cyclophosphane].
    Sheĭko EA; Shikhliarova AI; Kurkina TA
    Vopr Onkol; 2004; 50(5):576-9. PubMed ID: 15715100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of the effects of low-intensity monochromatic photodiode radiation and antitumor efficiency of cyclophosphamide injected with autoblood.
    Sheiko EA; Shikhlyarova AI; Maryanovskaya GIa; Kurkina TA; Leonteva DV
    Bull Exp Biol Med; 2011 May; 151(1):58-61. PubMed ID: 22442803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
    Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergism and attenuation effects of taurine on cyclophosphamide].
    Zhao N; Wang L; Mou HY; Liang M; Yue W
    Ai Zheng; 2009 Mar; 28(3):244-8. PubMed ID: 19619437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronometaanalysis: circasemiseptan (3.5-day) pattern in mitotic activity of murine sarcoma after treatment with cyclophosphamide.
    Focan C; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):401-6. PubMed ID: 8555441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12.
    Tsung K; Meko JB; Tsung YL; Peplinski GR; Norton JA
    J Immunol; 1998 Feb; 160(3):1369-77. PubMed ID: 9570556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
    Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
    Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined therapy of experimental tumors with the vaccinal strain of Venezulean encephalomyelitis virus].
    Urazova LN; Gromova AI
    Vopr Onkol; 2001; 47(1):78-80. PubMed ID: 11317543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the antitumor effectiveness of endoxan when administered in various ways].
    Zaitseva LA; Syrkin AB
    Vopr Onkol; 1969; 15(11):99-101. PubMed ID: 5368849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Potential of prevention of metastasizing with the aid of tumor-specific transfer-factor].
    Fil'chakov FV; Lën AD; Shumilina ES; Kukushkina SN; Shved VV; Grinevich IuA
    Vopr Onkol; 2011; 57(1):81-5. PubMed ID: 21598714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
    Kulik GI
    Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
    Ben-Hur H; Kossoy G; Zandbank J; Zusman I
    Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin metabolism in immunocompetent organs of tumor rats after autohemochemotherapy.
    Kaplieva IV
    Bull Exp Biol Med; 2007 Nov; 144(5):728-9. PubMed ID: 18683508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of three antineoplastic alkylating agents on DNA].
    Babaian IuS; Khudaverdian NV; Karapetian LG; Kazarian RS; Sogomonian LR
    Biofizika; 1997; 42(2):542-3. PubMed ID: 9172701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.